Ellen S. Rosenberg
Net Worth

Last updated:

What is Ellen S. Rosenberg net worth?

The estimated net worth of Ms. Ellen S. Rosenberg is at least $11,250,837 as of 7 Feb 2024. She owns shares worth $2,665,492 as insider, has earned $2,536,535 from insider trading and has received compensation worth at least $6,048,810 in Amicus Therapeutics, Inc..

What is the salary of Ellen S. Rosenberg?

Ms. Ellen S. Rosenberg salary is $672,090 per year as Chief Legal Officer & Corporation Sec. in Amicus Therapeutics, Inc..

How old is Ellen S. Rosenberg?

Ms. Ellen S. Rosenberg is 62 years old, born in 1963.

What stocks does Ellen S. Rosenberg currently own?

As insider, Ms. Ellen S. Rosenberg owns shares in one company:

Company Title Shares Price per share Total value
Amicus Therapeutics, Inc. (FOLD) Chief Legal Officer & Corporation Sec. 367,654 $7.25 $2,665,492

What does Amicus Therapeutics, Inc. do?

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

FOLD logo
FOLD
Amicus Therapeutics, Inc.
$7.25

Ellen S. Rosenberg insider trading

Amicus Therapeutics, Inc.

Ms. Ellen S. Rosenberg has made 12 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 31,839 units of FOLD stock on 24 Jan 2023. As of 7 Feb 2024 she still owns at least 367,654 units of FOLD stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Options (right to buy) 29,600 $5.16 $152,736
Option
Common Stock 29,600 $5.16 $152,736
Sale
Common Stock 29,600 $13 $384,830
Sale
Common Stock 400 $13 $5,200
Option
Stock Options (right to buy) 400 $5.16 $2,064
Option
Common Stock 400 $5.16 $2,064
Option
Common Stock 30,000 $5.16 $154,800
Sale
Common Stock 30,000 $14.21 $426,210
Option
Stock Options (right to buy) 30,000 $5.16 $154,800
Option
Stock Options (right to buy) 5,000 $5.16 $25,800
Option
Common Stock 5,000 $5.16 $25,800
Sale
Common Stock 5,000 $14.07 $70,325
Option
Common Stock 30,000 $5.16 $154,800
Option
Stock Options (right to buy) 30,000 $5.16 $154,800
Sale
Common Stock 30,000 $14 $420,090
Sale
Common Stock 31,839 $13.32 $424,000
Sale
Common Stock 11,123 $10.02 $111,475
Sale
Common Stock 11,122 $10.01 $111,276
Sale
Common Stock 11,018 $9.06 $99,801
Sale
Common Stock 30,000 $5.16 $154,800
Option
Common Stock 30,000 $5.16 $154,800
Option
Stock Options (right to buy) 30,000 $5.16 $154,800
Sale
Common Stock 22,100 $10.35 $228,647
Sale
Common Stock 10,448 $9.56 $99,883
Purchase
Common Stock 15,000 $7.67 $115,050

Amicus Therapeutics key executives

Amicus Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Mr. Bradley L. Campbell M.B.A. (49) Pres, Chief Operating Officer & Director
  • Mr. John F. Crowley (58) Chairman & Chief Executive Officer
  • Ms. Daphne E. Quimi CPA (59) Chief Financial Officer
  • Ms. Ellen S. Rosenberg (62) Chief Legal Officer & Corporation Sec.